Literature DB >> 22424014

Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction.

Eileen M Hsich1, Maria V Grau-Sepulveda, Adrian F Hernandez, Eric D Peterson, Lee H Schwamm, Deepak L Bhatt, Gregg C Fonarow.   

Abstract

BACKGROUND: There are no sex-specific survival comparisons between patients with heart failure (HF) with reduced and those with preserved ejection fraction. Large registries noting women have better survival than men combined HF patients with reduced and preserved EF. Other registries that compared patients with reduced and preserved EF did not analyze their data by sex. We sought to evaluate sex/EF differences in mortality and risk factors for survival in hospitalized patients with HF.
METHODS: We included hospitals fully participating in Get With The Guidelines-Heart Failure that admitted HF patients with reduced (EF <40%) or preserved (EF ≥50%) EF. The primary end point was in-hospital mortality. Multivariate generalized estimating equation logistic models were used to compute odds ratios accounting for hospital clustering.
RESULTS: The study cohort consisted of 51,428 patients with EF <40% (36% women, 64% men) and 37,699 patients with EF ≥50% (65% women, 35% men). Women compared with men with reduced and preserved EF were older and more likely to have hypertension, depression, or valvular heart disease and less likely to have coronary artery disease or peripheral vascular disease. There were no sex differences in in-hospital mortality (EF <40%, 2.69% women vs 2.89% men, P = .20; EF ≥50%, 2.61% women vs 2.62% men, P = .96), and risk factors such as age, systolic blood pressure, heart rate, and history of renal failure/dialysis were highly predictive of death for each sex/EF subgroup.
CONCLUSIONS: In a large, multicenter registry, we found that despite differences in baseline characteristics, women and men with reduced and preserved EF have similar in-hospital mortality and risk factors predicting death. Copyright Â
© 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22424014     DOI: 10.1016/j.ahj.2011.12.013

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  27 in total

1.  Advances in Cardiovascular Health in Women over the Past Decade: Guideline Recommendations for Practice.

Authors:  Pejman Raeisi-Giglou; Annabelle Santos Volgman; Hena Patel; Susan Campbell; Amparo Villablanca; Eileen Hsich
Journal:  J Womens Health (Larchmt)       Date:  2017-07-17       Impact factor: 2.681

2.  The contribution of comorbidities to mortality in hospitalized patients with heart failure.

Authors:  Oliver Riedel; C Ohlmeier; D Enders; A Elsässer; D Vizcaya; A Michel; S Eberhard; N Schlothauer; J Berg; E Garbe
Journal:  Clin Res Cardiol       Date:  2018-02-05       Impact factor: 5.460

Review 3.  Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.

Authors:  Robert J Mentz; Jacob P Kelly; Thomas G von Lueder; Adriaan A Voors; Carolyn S P Lam; Martin R Cowie; Keld Kjeldsen; Ewa A Jankowska; Dan Atar; Javed Butler; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2014-11-24       Impact factor: 24.094

Review 4.  Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes.

Authors:  Andrew P Ambrosy; Mihai Gheorghiade; Ovidiu Chioncel; Robert J Mentz; Javed Butler
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 5.  Cardiovascular biomarkers and sex: the case for women.

Authors:  Lori B Daniels; Alan S Maisel
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

Review 6.  Heart Failure with Reduced Ejection Fraction in Women: Epidemiology, Outcomes, and Treatment.

Authors:  Gina Mentzer; Eileen M Hsich
Journal:  Heart Fail Clin       Date:  2018-10-24       Impact factor: 3.179

7.  Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy.

Authors:  Zahara Meghji; Anita Nguyen; Benish Fatima; Jeffrey B Geske; Rick A Nishimura; Steve R Ommen; Brian D Lahr; Joseph A Dearani; Hartzell V Schaff
Journal:  JAMA Cardiol       Date:  2019-03-01       Impact factor: 14.676

8.  A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study.

Authors:  Nisha Bansal; Martin Keane; Patrice Delafontaine; Daniel Dries; Elyse Foster; Crystal A Gadegbeku; Alan S Go; L Lee Hamm; John W Kusek; Akinlolu O Ojo; Mahboob Rahman; Kaixiang Tao; Jackson T Wright; Dawei Xie; Chi-yuan Hsu
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 8.237

9.  Sex differences and in-hospital outcomes in patients undergoing mechanical circulatory support implantation.

Authors:  Colleen K McIlvennan; JoAnn Lindenfeld; David P Kao
Journal:  J Heart Lung Transplant       Date:  2016-08-20       Impact factor: 10.247

10.  Variables of importance in the Scientific Registry of Transplant Recipients database predictive of heart transplant waitlist mortality.

Authors:  Eileen M Hsich; Lucy Thuita; Dennis M McNamara; Joseph G Rogers; Maryam Valapour; Lee R Goldberg; Clyde W Yancy; Eugene H Blackstone; Hemant Ishwaran
Journal:  Am J Transplant       Date:  2019-02-13       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.